Studies of the Mechanism of Action of Platinum(II) Complexes with Potent Cytotoxicity in Human Cancer Cells
- 6 August 2009
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (17), 5474-5484
- https://doi.org/10.1021/jm9007104
Abstract
We have examined the biological activity of 12 platinum(II)-based DNA intercalators of the type [Pt(IL)(AL)]2+, where IL is an intercalating ligand (1,10-phenanthroline or a methylated derivative) and AL is an ancillary ligand (diaminocyclohexane, diphenylethylenediamine or 1,2-bis(4-fluorophenyl)-1,2-ethylenediamine). The chiral compounds (1−9) and the racemic compounds (10−12) were tested against a panel of human cancer cell lines, with a number of complexes displaying activity significantly greater than that of cisplatin (up to 100-fold increase in activity in the A-427 cell line). The activity of the complexes containing diphenylethylenediamine (8 and 9) and 1,2-bis(4-fluorophenyl)-1,2-ethylenediamine (10−12) was significantly lower compared to the complexes containing diaminocyclohexane (1−7). Further in vitro testing, such as DNA unwinding, competition assays, and DNase 1 footprinting, was conducted on the most active compound (5) and its enantiomer (6) to provide information about the mechanism of action. These complexes display activity in cisplatin resistant cell lines, have higher cellular uptake than cisplatin, and do not activate caspase-3 as cisplatin does, indicating that these complexes exhibit a different mechanism of action.Keywords
This publication has 29 references indexed in Scilit:
- The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalatorsJournal of Inorganic Biochemistry, 2007
- Chiral Platinum(II) Metallointercalators with Potent in vitro Cytotoxic ActivityChemMedChem, 2007
- (4,7-Dimethyl-1,10-phenanthroline)(ethylenediamine)platinum(II) dichloride tris(deuterium oxide) solvateActa Crystallographica Section E: Crystallographic Communications, 2006
- Synthesis, Characterisation and Biological Activity of Chiral Platinum(II) ComplexesEuropean Journal of Inorganic Chemistry, 2006
- Light-Activated Destruction of Cancer Cell Nuclei by Platinum Diazide ComplexesCell Chemical Biology, 2006
- [1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen LevelArchiv der Pharmazie, 2004
- DNA binding and biological activity of some platinum(ii) intercalating compounds containing methyl-substituted 1,10-phenanthrolinesElectronic supplementary information (ESI) available: Binding data determined for platinum complexes bound to calf thymus DNA, linear dicroism spectra, Absorption spectra of the DNA alone and of the platinum complexes with DNA and solubilities of complexes in water. See http://www.rsc.org/suppdata/dt/b3/b316511f/Dalton Transactions, 2004
- Platinum compounds with estrogen receptor affinityCancer Treatment Reviews, 1990
- Differential scanning calorimetric study of the effect of intercalators and other kinds of DNA-binding drugs on the stepwise melting of plasmid DNAJournal of Molecular Biology, 1990
- Tumor Inhibiting [1,2‐Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes, III1): Evaluation of the Mammary Tumor Inhibiting PropertiesArchiv der Pharmazie, 1990